NLA News

JACKSONVILLE, Fla. (September 2016) — The Foundation of the National Lipid Association, in conjunction with National Cholesterol Education Month, will launch the RADAR Campaign (RADAR: RAre Disease AwaReness) providing resources and tools to both patients and healthcare professionals designed... more

Section:

0
No votes yet

TORONTO (June 10, 2018) – Jonathan C. Cohen, PhD, and Nabil G. Seidah, PhD, each received a 2018 National Lipid Association/Foundation of the NLA Akira Endo Award for Achievements in the Development of Treatments to Prevent Atherosclerosis at the XVIIIth International Symposium on... more

Section:

0
No votes yet

Register for the NLA Annual Business Meeting by clicking here.  Join us on Monday, June 8 from 6:00 – 6:30 PM ET for the NLA’s Annual Business Meeting for important NLA updates and award announcements: Message from the President, Antonio Gotto, MD, DPhil, FNLA Award... more

Section:

0
No votes yet

The NLA was recently awarded Best Practice in Educational Design & Evaluation by the National Association of Medical Education Companies (NAMEC). The award recognizes the work of the NLA, along with its educational partner, MCM Education, for a series of activities in 2012-2013 titled Managing... more

Section:

0
No votes yet

The outcomes of a Global think tank on the clinical considerations & management of lipoprotein(a): The top questions and answers regarding what clinicians need to know published online in Progress in Cardiovascular Disease. Participating organizations include the Association of Black... more

Section:

0
No votes yet

By Peter H. Jones, MD, FACP, FNLA The National Lipid Association (NLA) is excited about the upcoming 2014 American Heart Association (AHA) Scientific Sessions (Nov. 15-19, Chicago). This is the premier meeting exploring all of the latest news and science related to heart and vascular disease,... more

Section:

0
No votes yet

THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has broadened the approved use of Repatha® (evolocumab) to include adults at increased risk for major adverse cardiovascular events (MACE) due to... more

Section:

0
No votes yet

Pledges to the Foundation of the National Lipid Association   The Foundation of the National Lipid Association has joined #GivingTuesday, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to... more

Section:

0
No votes yet

This year, Familial Hypercholesterolemia (FH) Awareness Day is on September 24, 2016. It was initiated by The FH Foundation as part of their mission to raise awareness of FH in the public. The FH Foundation is a patient-centered nonprofit organization dedicated to education,... more

Section:

0
No votes yet

The National Lipid Association has been quite busy since the 2018 Scientific Sessions in Las Vegas. Below are some of the highlights of the last month. Stay tuned for more recurring updates from our organization.   Guidelines Dissemination Task Force With the anticipated November... more

Section:

0
No votes yet